A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)
Clinical trial NCT07193550 · RECRUITING
Trial details
- NCT number
- NCT07193550
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-05
- Primary completion
- 2029-10-31
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.